Boston Scientific Invests $1.5 Billion in Heart Valve Company Mirus

What’s happening

Boston Scientific invested $1.5 billion in Mirus with the option to eventually buy its heart valve business.

What’s changing / Business impact

Expansion in:

• cardiovascular devices
• heart valve technology

Increased competition in cardiac treatment markets.

Why this matters

Heart disease remains one of the biggest health problems in the world.

This shows:

• medical device companies are heavily investing in advanced heart treatments
• cardiovascular care remains a major healthcare growth sector

CORE TAKEAWAY